Full Text View
Tabular View
No Study Results Posted
Related Studies
TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients
This study is currently recruiting participants.
Study NCT00133887   Information provided by Hospices Civils de Lyon
First Received: August 23, 2005   Last Updated: February 6, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Skin Cancer
Kidney Transplantation
Additional conditions recognized in this trial
Skin Neoplasms
More general conditions related to this trial
Neoplasms
Neoplasms by Site
Skin Diseases
Interventions listed in this trial
rapamycin
ciclosporine
tacrolimus
Additional drug interventions recognized in this trial
Sirolimus
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antineoplastic
Antifungal Agents
Antineoplastic Agents
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Hospices Civils de Lyon


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services